{"transactions":[{"id":4640188,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69529,"kind":"person","name":"Anand Bhaskar","position":1,"cik":"0001890784","reported_name":"Anand Bhaskar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-10-14T20:07:18.000Z","date":"2026-10-08","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted under the Issuer's Amended and Restated 2020 Stock Incentive Plan. The restricted stock units vest on October 8, 2029, subject to the Reporting Person continuing his employment with the Issuer, and will entitle the Reporting Person to one share of the Issuer's common stock for each restricted stock unit that vests."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan."}],"balance_after":261047,"source":{"system":"sec-edgar","filing":"0001890784-26-000006","document":"wk-form4_1792008434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890784/000189078426000006/wk-form4_1792008434.xml","form_type":"4"}},{"id":739292,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-12T18:35:11.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":3810000,"price":13.12,"value":49987200.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":573883879,"source":{"system":"sec-edgar","filing":"0001507650-26-000007","document":"wk-form4_1781289308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765026000007/wk-form4_1781289308.xml","form_type":"4"}},{"id":740462,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-12T16:28:50.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":3810000,"price":13.12,"value":49987200.0,"ownership":{"direct":true},"balance_after":573883879,"source":{"system":"sec-edgar","filing":"0001055919-26-000007","document":"wk-form4_1781281727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591926000007/wk-form4_1781281727.xml","form_type":"4"}},{"id":750017,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-04T22:08:26.000Z","date":"2026-06-04","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":14.6,"value":1460000.0,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Spouse of Reporting Person as Trustee"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":25824474,"source":{"system":"sec-edgar","filing":"0001055919-26-000005","document":"wk-form4_1780610903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591926000005/wk-form4_1780610903.xml","form_type":"4"}},{"id":749283,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-04T21:45:03.000Z","date":"2026-06-04","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":14.6,"value":1460000.0,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":25824474,"source":{"system":"sec-edgar","filing":"0001507650-26-000005","document":"wk-form4_1780609499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765026000005/wk-form4_1780609499.xml","form_type":"4"}},{"id":749212,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38041,"kind":"person","name":"Soni Manmeet Singh","position":1,"cik":"0001569769","reported_name":"Soni Manmeet Singh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and CFO"}}],"security":"Common Stock","published_at":"2026-06-04T20:40:51.000Z","date":"2026-06-04","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":14.43,"value":360750.0,"ownership":{"direct":true},"balance_after":3123603,"source":{"system":"sec-edgar","filing":"0001569769-26-000004","document":"wk-form4_1780605646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1569769/000156976926000004/wk-form4_1780605646.xml","form_type":"4"}},{"id":749211,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38041,"kind":"person","name":"Soni Manmeet Singh","position":1,"cik":"0001569769","reported_name":"Soni Manmeet Singh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and CFO"}}],"security":"Common Stock","published_at":"2026-06-04T20:40:51.000Z","date":"2026-06-04","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":14.46,"value":361500.0,"ownership":{"direct":true},"balance_after":3098603,"source":{"system":"sec-edgar","filing":"0001569769-26-000004","document":"wk-form4_1780605646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1569769/000156976926000004/wk-form4_1780605646.xml","form_type":"4"}},{"id":941144,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69529,"kind":"person","name":"Anand Bhaskar","position":1,"cik":"0001890784","reported_name":"Anand Bhaskar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-12T16:01:39.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 8, 2026. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on January 8, 2027."}],"balance_after":30000,"derivative":{"exercise_price":18.83,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001890784-26-000003","document":"wk-form4_1768251691.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890784/000189078426000003/wk-form4_1768251691.xml","form_type":"4"}},{"id":945842,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:52:54.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":11232,"price":8.76,"value":98392.32,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued to the reporting person's spouse pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person's spouse remaining as a non-salaried director on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or any other purpose."}],"balance_after":11232,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":11232},"source":{"system":"sec-edgar","filing":"0001507650-26-000003","document":"wk-form4_1767747171.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765026000003/wk-form4_1767747171.xml","form_type":"4"}},{"id":947733,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:50:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":11232,"price":8.76,"value":98392.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":11232,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":11232},"source":{"system":"sec-edgar","filing":"0001055919-26-000003","document":"wk-form4_1767747017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591926000003/wk-form4_1767747017.xml","form_type":"4"}},{"id":945701,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69938,"kind":"person","name":"Xia Yu","position":1,"cik":"0001963544","reported_name":"Xia Yu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T23:52:50.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001963544-26-000002","document":"wk-form4_1767743566.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000196354426000002/wk-form4_1767743566.xml","form_type":"4"}},{"id":946594,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":26930,"kind":"person","name":"Huber Jeff","position":1,"cik":"0001463740","reported_name":"Huber Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T23:49:36.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":9885,"price":8.76,"value":86592.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $86,600."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":9885,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":9885},"source":{"system":"sec-edgar","filing":"0001463740-26-000003","document":"wk-form4_1767743373.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463740/000146374026000003/wk-form4_1767743373.xml","form_type":"4"}},{"id":946593,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":26930,"kind":"person","name":"Huber Jeff","position":1,"cik":"0001463740","reported_name":"Huber Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T23:49:36.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001463740-26-000003","document":"wk-form4_1767743373.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463740/000146374026000003/wk-form4_1767743373.xml","form_type":"4"}},{"id":945697,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T23:39:57.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3219,"price":8.76,"value":28198.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $28,200."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":3219,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":3219},"source":{"system":"sec-edgar","filing":"0001827015-26-000002","document":"wk-form4_1767742793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000182701526000002/wk-form4_1767742793.xml","form_type":"4"}},{"id":945696,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T23:39:57.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001827015-26-000002","document":"wk-form4_1767742793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000182701526000002/wk-form4_1767742793.xml","form_type":"4"}},{"id":945841,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T18:55:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":7180,"price":8.76,"value":62896.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $62,900."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":7180,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":7180},"source":{"system":"sec-edgar","filing":"0001507567-26-000003","document":"wk-form4_1767743714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000150756726000003/wk-form4_1767743714.xml","form_type":"4"}},{"id":945840,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T18:55:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001507567-26-000003","document":"wk-form4_1767743714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000150756726000003/wk-form4_1767743714.xml","form_type":"4"}},{"id":946310,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69981,"kind":"person","name":"Ronaghi Mostafa","position":1,"cik":"0001441876","reported_name":"Ronaghi Mostafa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T18:44:55.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001441876-26-000002","document":"wk-form4_1767743091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441876/000144187626000002/wk-form4_1767743091.xml","form_type":"4"}},{"id":945767,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T18:43:10.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":17796,"price":8.76,"value":155892.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $155,900."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":17796,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":17796},"source":{"system":"sec-edgar","filing":"0001561736-26-000002","document":"wk-form4_1767742986.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000156173626000002/wk-form4_1767742986.xml","form_type":"4"}},{"id":945766,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T18:43:10.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":17.52,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001561736-26-000002","document":"wk-form4_1767742986.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000156173626000002/wk-form4_1767742986.xml","form_type":"4"}},{"id":1014137,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69938,"kind":"person","name":"Xia Yu","position":1,"cik":"0001963544","reported_name":"Xia Yu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T01:06:30.000Z","date":"2025-10-21","kind":"purchase","planned":false,"acquired":true,"shares":533617,"price":18.74,"value":9999982.58,"ownership":{"direct":false,"nature":"Akeso, Inc."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 25.96% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest."}],"balance_after":32057147,"source":{"system":"sec-edgar","filing":"0001963544-25-000004","document":"wk-form4_1761267986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000196354425000004/wk-form4_1761267986.xml","form_type":"4"}},{"id":1014140,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38041,"kind":"person","name":"Soni Manmeet Singh","position":1,"cik":"0001569769","reported_name":"Soni Manmeet Singh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and CFO"}}],"security":"Common Stock","published_at":"2025-10-23T20:10:15.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":53361,"price":18.74,"value":999985.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."}],"balance_after":3073603,"source":{"system":"sec-edgar","filing":"0001569769-25-000002","document":"wk-form4_1761250212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1569769/000156976925000002/wk-form4_1761250212.xml","form_type":"4"}},{"id":1014317,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:08:30.000Z","date":"2025-10-21","kind":"purchase","planned":false,"acquired":true,"shares":26680,"price":18.74,"value":499983.2,"ownership":{"direct":false,"nature":"Immediate family member of Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":76680,"source":{"system":"sec-edgar","filing":"0001055919-25-000003","document":"wk-form4_1761250107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591925000003/wk-form4_1761250107.xml","form_type":"4"}},{"id":1014316,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:08:30.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":266808,"price":18.74,"value":4999981.92,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Spouse of Reporting Person as Trustee"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":25724474,"source":{"system":"sec-edgar","filing":"0001055919-25-000003","document":"wk-form4_1761250107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591925000003/wk-form4_1761250107.xml","form_type":"4"}},{"id":1014315,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:08:30.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":13980789,"price":18.74,"value":261999985.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."}],"balance_after":570073879,"source":{"system":"sec-edgar","filing":"0001055919-25-000003","document":"wk-form4_1761250107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000105591925000003/wk-form4_1761250107.xml","form_type":"4"}},{"id":1014148,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:06:32.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":13980789,"price":18.74,"value":261999985.86,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":570073879,"source":{"system":"sec-edgar","filing":"0001507650-25-000003","document":"wk-form4_1761249988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765025000003/wk-form4_1761249988.xml","form_type":"4"}},{"id":1014147,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:06:32.000Z","date":"2025-10-21","kind":"purchase","planned":false,"acquired":true,"shares":26680,"price":18.74,"value":499983.2,"ownership":{"direct":false,"nature":"Immediate family member"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":76680,"source":{"system":"sec-edgar","filing":"0001507650-25-000003","document":"wk-form4_1761249988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765025000003/wk-form4_1761249988.xml","form_type":"4"}},{"id":1014146,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-23T20:06:32.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":266808,"price":18.74,"value":4999981.92,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":25724474,"source":{"system":"sec-edgar","filing":"0001507650-25-000003","document":"wk-form4_1761249988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000150765025000003/wk-form4_1761249988.xml","form_type":"4"}},{"id":1014264,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69529,"kind":"person","name":"Anand Bhaskar","position":1,"cik":"0001890784","reported_name":"Anand Bhaskar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-10-23T16:11:53.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":26680,"price":18.74,"value":499983.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan."}],"balance_after":159751,"source":{"system":"sec-edgar","filing":"0001890784-25-000005","document":"wk-form4_1761250310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890784/000189078425000005/wk-form4_1761250310.xml","form_type":"4"}},{"id":1035703,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69529,"kind":"person","name":"Anand Bhaskar","position":1,"cik":"0001890784","reported_name":"Anand Bhaskar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-19T16:45:00.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on September 18, 2025. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on September 18, 2026."}],"balance_after":50000,"derivative":{"exercise_price":19.23,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001890784-25-000003","document":"wk-form4_1758314696.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890784/000189078425000003/wk-form4_1758314696.xml","form_type":"4"}},{"id":1042551,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T23:36:31.000Z","date":"2025-09-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":18.07,"value":90350.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose"}],"balance_after":556093090,"source":{"system":"sec-edgar","filing":"0001599298-25-000143","document":"wk-form4_1757633787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000143/wk-form4_1757633787.xml","form_type":"4"}},{"id":1042550,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T23:36:31.000Z","date":"2025-09-10","kind":"purchase","planned":false,"acquired":true,"shares":333394,"price":17.68,"value":5894405.92,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.49 to $17.89 per share, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose"}],"balance_after":556088090,"source":{"system":"sec-edgar","filing":"0001599298-25-000143","document":"wk-form4_1757633787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000143/wk-form4_1757633787.xml","form_type":"4"}},{"id":1043204,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T23:32:04.000Z","date":"2025-09-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":18.07,"value":90350.0,"ownership":{"direct":true},"balance_after":556093090,"source":{"system":"sec-edgar","filing":"0001599298-25-000142","document":"wk-form4_1757633519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000142/wk-form4_1757633519.xml","form_type":"4"}},{"id":1043203,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-11T23:32:04.000Z","date":"2025-09-10","kind":"purchase","planned":false,"acquired":true,"shares":333394,"price":17.68,"value":5894405.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.49 to $17.89 per share, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":556088090,"source":{"system":"sec-edgar","filing":"0001599298-25-000142","document":"wk-form4_1757633519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000142/wk-form4_1757633519.xml","form_type":"4"}},{"id":1127281,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T21:01:16.000Z","date":"2025-05-30","kind":"exercise","planned":false,"acquired":false,"shares":74545,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 30, 2025, the Reporting Person's spouse exercised an option to purchase 74,545 shares of the Issuer's common stock at an exercise price of $2.64 per share. The Reporting Person's spouse did not sell the underlying shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option vested in four equal quarterly installments on March 31, June 30, September 30 and December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":74545},"source":{"system":"sec-edgar","filing":"0001599298-25-000107","document":"wk-form4_1748898068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000107/wk-form4_1748898068.xml","form_type":"4"}},{"id":1127280,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-02T21:01:16.000Z","date":"2025-05-30","kind":"exercise","planned":false,"acquired":true,"shares":74545,"price":2.64,"value":196798.8,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 30, 2025, the Reporting Person's spouse exercised an option to purchase 74,545 shares of the Issuer's common stock at an exercise price of $2.64 per share. The Reporting Person's spouse did not sell the underlying shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":555754696,"source":{"system":"sec-edgar","filing":"0001599298-25-000107","document":"wk-form4_1748898068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000107/wk-form4_1748898068.xml","form_type":"4"}},{"id":1128156,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T20:55:56.000Z","date":"2025-05-30","kind":"exercise","planned":false,"acquired":false,"shares":74545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 30, 2025, the Reporting Person exercised an option to purchase 74,545 shares of the Issuer's common stock at an exercise price of $2.64 per share. The Reporting Person did not sell the underlying shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option vested in four equal quarterly installments on March 31, June 30, September 30 and December 31, 2024."}],"balance_after":0,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":74545},"source":{"system":"sec-edgar","filing":"0001599298-25-000106","document":"wk-form4_1748897749.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000106/wk-form4_1748897749.xml","form_type":"4"}},{"id":1128155,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-02T20:55:56.000Z","date":"2025-05-30","kind":"exercise","planned":false,"acquired":true,"shares":74545,"price":2.64,"value":196798.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 30, 2025, the Reporting Person exercised an option to purchase 74,545 shares of the Issuer's common stock at an exercise price of $2.64 per share. The Reporting Person did not sell the underlying shares."}],"balance_after":555754696,"source":{"system":"sec-edgar","filing":"0001599298-25-000106","document":"wk-form4_1748897749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000106/wk-form4_1748897749.xml","form_type":"4"}},{"id":1162276,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38041,"kind":"person","name":"Soni Manmeet Singh","position":1,"cik":"0001569769","reported_name":"Soni Manmeet Singh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:13:55.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":11200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."}],"balance_after":11200000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":11200000},"source":{"system":"sec-edgar","filing":"0001599298-25-000095","document":"wk-form4_1746137627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1569769/000159929825000095/wk-form4_1746137627.xml","form_type":"4"}},{"id":1162746,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:09:55.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":9590558,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":9590558,"derivative":{"exercise_price":1.68,"expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":9590558},"source":{"system":"sec-edgar","filing":"0001599298-25-000093","document":"wk-form4_1746137388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000093/wk-form4_1746137388.xml","form_type":"4"}},{"id":1162745,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:09:55.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":400000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-09-09","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001599298-25-000093","document":"wk-form4_1746137388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000093/wk-form4_1746137388.xml","form_type":"4"}},{"id":1162744,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:09:55.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":1040000,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":1040000,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":1040000},"source":{"system":"sec-edgar","filing":"0001599298-25-000093","document":"wk-form4_1746137388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000093/wk-form4_1746137388.xml","form_type":"4"}},{"id":1162311,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:03:44.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":9590558,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."}],"balance_after":9590558,"derivative":{"exercise_price":1.68,"expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":9590558},"source":{"system":"sec-edgar","filing":"0001599298-25-000091","document":"wk-form4_1746137015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000091/wk-form4_1746137015.xml","form_type":"4"}},{"id":1162310,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:03:44.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."}],"balance_after":400000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-09-09","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001599298-25-000091","document":"wk-form4_1746137015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000091/wk-form4_1746137015.xml","form_type":"4"}},{"id":1162309,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T22:03:44.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":1040000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025."}],"balance_after":1040000,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":1040000},"source":{"system":"sec-edgar","filing":"0001599298-25-000091","document":"wk-form4_1746137015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000091/wk-form4_1746137015.xml","form_type":"4"}},{"id":1162615,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69529,"kind":"person","name":"Anand Bhaskar","position":1,"cik":"0001890784","reported_name":"Anand Bhaskar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T18:17:22.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on January 12, 2026."}],"balance_after":75000,"derivative":{"exercise_price":17.85,"expiration_date":"2035-01-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001599298-25-000097","document":"wk-form4_1746137834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1890784/000159929825000097/wk-form4_1746137834.xml","form_type":"4"}},{"id":1162614,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69529,"kind":"person","name":"Anand Bhaskar","position":1,"cik":"0001890784","reported_name":"Anand Bhaskar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-01T18:17:22.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":600000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest in four equal annual installments, with the first such installment occurring on December 31, 2025."}],"balance_after":600000,"derivative":{"exercise_price":3.85,"expiration_date":"2034-04-02","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001599298-25-000097","document":"wk-form4_1746137834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890784/000159929825000097/wk-form4_1746137834.xml","form_type":"4"}},{"id":1174580,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2025-04-09T21:19:31.000Z","date":"2025-04-08","kind":"other","planned":false,"acquired":true,"shares":3985055,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 8, 2025, the Reporting Person's spouse exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":1.58,"exercise_date":"2020-06-24","expiration_date":"2029-12-24","underlying":"Common Stock","underlying_shares":3985055},"source":{"system":"sec-edgar","filing":"0001599298-25-000060","document":"wk-form4_1744233562.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000060/wk-form4_1744233562.xml","form_type":"4"}},{"id":1174579,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-09T21:19:31.000Z","date":"2025-04-08","kind":"other","planned":false,"acquired":true,"shares":3985055,"price":1.58,"value":6296386.9,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 8, 2025, the Reporting Person's spouse exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":555680151,"source":{"system":"sec-edgar","filing":"0001599298-25-000060","document":"wk-form4_1744233562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000060/wk-form4_1744233562.xml","form_type":"4"}},{"id":1174885,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2025-04-09T21:12:06.000Z","date":"2025-04-08","kind":"other","planned":false,"acquired":true,"shares":3985055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 8, 2025, the Reporting Person exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share."}],"balance_after":0,"derivative":{"exercise_price":1.58,"exercise_date":"2020-06-24","expiration_date":"2029-12-24","underlying":"Common Stock","underlying_shares":3985055},"source":{"system":"sec-edgar","filing":"0001599298-25-000058","document":"wk-form4_1744233117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000058/wk-form4_1744233117.xml","form_type":"4"}},{"id":1174884,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-09T21:12:06.000Z","date":"2025-04-08","kind":"other","planned":false,"acquired":true,"shares":3985055,"price":1.58,"value":6296386.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 8, 2025, the Reporting Person exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share."}],"balance_after":555680151,"source":{"system":"sec-edgar","filing":"0001599298-25-000058","document":"wk-form4_1744233117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000058/wk-form4_1744233117.xml","form_type":"4"}},{"id":1303640,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69529,"kind":"person","name":"Anand Bhaskar","position":1,"cik":"0001890784","reported_name":"Anand Bhaskar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-14T16:06:34.000Z","date":"2025-01-12","kind":"grant","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not Applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 12, 2025. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on January 12, 2026."}],"balance_after":75000,"derivative":{"exercise_price":17.85,"expiration_date":"2035-01-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001599298-25-000036","document":"wk-form4_1736888785.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890784/000159929825000036/wk-form4_1736888785.xml","form_type":"4"}},{"id":1311553,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:49:10.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10724,"price":9.18,"value":98446.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the Director Retainer Option Election Plan of issuer in lieu of retainer fees of $98,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":10724,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10724},"source":{"system":"sec-edgar","filing":"0001599298-25-000030","document":"wk-form4_1736210941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929825000030/wk-form4_1736210941.xml","form_type":"4"}},{"id":1309853,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:39:43.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10724,"price":9.18,"value":98446.32,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025 to the Reporting Person's spouse. The shares underlying the option shall vest in four quarterly installments, subject to continued service on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":10724,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":10724},"source":{"system":"sec-edgar","filing":"0001599298-25-000029","document":"wk-form4_1736210375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929825000029/wk-form4_1736210375.xml","form_type":"4"}},{"id":1310443,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":26930,"kind":"person","name":"Huber Jeff","position":1,"cik":"0001463740","reported_name":"Huber Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:30:11.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-25-000028","document":"wk-form4_1736209802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463740/000159929825000028/wk-form4_1736209802.xml","form_type":"4"}},{"id":1309729,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69938,"kind":"person","name":"Xia Yu","position":1,"cik":"0001963544","reported_name":"Xia Yu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:24:29.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5438,"price":9.18,"value":49920.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $49,900."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":5438,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":5438},"source":{"system":"sec-edgar","filing":"0001599298-25-000027","document":"wk-form4_1736209460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929825000027/wk-form4_1736209460.xml","form_type":"4"}},{"id":1309728,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69938,"kind":"person","name":"Xia Yu","position":1,"cik":"0001963544","reported_name":"Xia Yu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:24:29.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-25-000027","document":"wk-form4_1736209460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929825000027/wk-form4_1736209460.xml","form_type":"4"}},{"id":1309724,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:17:50.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":3073,"price":9.18,"value":28210.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the Director Retainer Option Election Plan of issuer in lieu of retainer fees of $28,200."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":3073,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":3073},"source":{"system":"sec-edgar","filing":"0001599298-25-000026","document":"wk-form4_1736209060.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929825000026/wk-form4_1736209060.xml","form_type":"4"}},{"id":1309723,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:17:50.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-25-000026","document":"wk-form4_1736209060.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929825000026/wk-form4_1736209060.xml","form_type":"4"}},{"id":1310382,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69981,"kind":"person","name":"Ronaghi Mostafa","position":1,"cik":"0001441876","reported_name":"Ronaghi Mostafa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T19:11:22.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-25-000025","document":"wk-form4_1736208674.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441876/000159929825000025/wk-form4_1736208674.xml","form_type":"4"}},{"id":1309775,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T19:05:34.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":16991,"price":9.18,"value":155977.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuers Director Retainer Option Election Plan in lieu of retainer fees of $155,900"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":16991,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":16991},"source":{"system":"sec-edgar","filing":"0001599298-25-000023","document":"wk-form4_1736208323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929825000023/wk-form4_1736208323.xml","form_type":"4"}},{"id":1309774,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T19:05:34.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-25-000023","document":"wk-form4_1736208323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929825000023/wk-form4_1736208323.xml","form_type":"4"}},{"id":1309852,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T18:57:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6855,"price":9.18,"value":62928.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the Director Retainer Option Election Plan of issuer in lieu of retainer fees of $62,900."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":6855,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":6855},"source":{"system":"sec-edgar","filing":"0001599298-25-000022","document":"wk-form4_1736207824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000159929825000022/wk-form4_1736207824.xml","form_type":"4"}},{"id":1309851,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T18:57:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":18.35,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-25-000022","document":"wk-form4_1736207824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000159929825000022/wk-form4_1736207824.xml","form_type":"4"}},{"id":1386511,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-10-15T17:08:13.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on October 11, 2024. The shares underlying the option shall vest in four equal annual installments, subject to the reporting person continuing to serve as a member of the Strategic Advisory Committee of the Board, with the first installment occurring on October 11, 2025."}],"balance_after":200000,"derivative":{"exercise_price":19.95,"expiration_date":"2034-10-11","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001599298-24-000150","document":"wk-form4_1729026485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929824000150/wk-form4_1729026485.xml","form_type":"4"}},{"id":1391569,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2024-10-03T20:54:29.000Z","date":"2024-10-03","kind":"other","planned":false,"acquired":false,"shares":315681,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 3, 2024, the Shaun Zanganeh Irrevocable Trust exercised a warrant to purchase 315,681 shares of the Issuer's common stock at an exercise price of $1.58 per share."}],"balance_after":0,"derivative":{"exercise_price":1.58,"exercise_date":"2020-06-24","expiration_date":"2029-12-24","underlying":"Common Stock","underlying_shares":315681},"source":{"system":"sec-edgar","filing":"0001599298-24-000146","document":"wk-form4_1727988861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000146/wk-form4_1727988861.xml","form_type":"4"}},{"id":1391568,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-03T20:54:29.000Z","date":"2024-10-03","kind":"other","planned":false,"acquired":true,"shares":315681,"price":1.58,"value":498775.98,"ownership":{"direct":false,"nature":"By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 3, 2024, the Shaun Zanganeh Irrevocable Trust exercised a warrant to purchase 315,681 shares of the Issuer's common stock at an exercise price of $1.58 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":10199776,"source":{"system":"sec-edgar","filing":"0001599298-24-000146","document":"wk-form4_1727988861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000146/wk-form4_1727988861.xml","form_type":"4"}},{"id":1407469,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-13T23:29:45.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":44052,"price":22.7,"value":999980.4,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee, at a purchase price of $22.70 per share. The transaction closed on September 13, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":24967852,"source":{"system":"sec-edgar","filing":"0001599298-24-000141","document":"wk-form4_1726270177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000141/wk-form4_1726270177.xml","form_type":"4"}},{"id":1407968,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-13T22:25:05.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":3325991,"price":22.7,"value":75499995.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person at a purchase price of $22.70 per share. The transaction closed on September 13, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes shares underlying options and warrants held by the Reporting Person."}],"balance_after":551695096,"source":{"system":"sec-edgar","filing":"0001599298-24-000139","document":"wk-form4_1726266298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929824000139/wk-form4_1726266298.xml","form_type":"4"}},{"id":1407628,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":26930,"kind":"person","name":"Huber Jeff","position":1,"cik":"0001463740","reported_name":"Huber Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T21:40:21.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":44052,"price":22.7,"value":999980.4,"ownership":{"direct":false,"nature":"By Caspian Capital LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to Caspian Capital LLC ('Caspian Capital') at a purchase price of $22.70 per share. The transaction closed on September 13, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager and member of Caspian Capital."}],"balance_after":44052,"source":{"system":"sec-edgar","filing":"0001599298-24-000138","document":"wk-form4_1726263613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463740/000159929824000138/wk-form4_1726263613.xml","form_type":"4"}},{"id":1407426,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38041,"kind":"person","name":"Soni Manmeet Singh","position":1,"cik":"0001569769","reported_name":"Soni Manmeet Singh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and CFO"}}],"security":"Common Stock","published_at":"2024-09-13T21:29:01.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":44052,"price":22.7,"value":999980.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person at a purchase price of $22.70 per share. The transaction closed on September 13, 2024."}],"balance_after":3020242,"source":{"system":"sec-edgar","filing":"0001599298-24-000136","document":"wk-form4_1726262933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1569769/000159929824000136/wk-form4_1726262933.xml","form_type":"4"}},{"id":1407834,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69529,"kind":"person","name":"Anand Bhaskar","position":1,"cik":"0001890784","reported_name":"Anand Bhaskar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-09-13T17:26:07.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":22026,"price":22.7,"value":499990.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person at a purchase price of $22.70 per share. The transaction closed on September 13, 2024."}],"balance_after":131426,"source":{"system":"sec-edgar","filing":"0001599298-24-000135","document":"wk-form4_1726262759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890784/000159929824000135/wk-form4_1726262759.xml","form_type":"4"}},{"id":1424019,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38041,"kind":"person","name":"Soni Manmeet Singh","position":1,"cik":"0001569769","reported_name":"Soni Manmeet Singh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and CFO"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-08-23T20:44:41.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":2800000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 11,200,000 shares underlying options which were granted on October 13, 2023 that remain subject to the satisfaction of performance conditions."}],"balance_after":2800000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":2800000},"source":{"system":"sec-edgar","filing":"0001599298-24-000125","document":"wk-form4_1724445873.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1569769/000159929824000125/wk-form4_1724445873.xml","form_type":"4"}},{"id":1424047,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-08-23T20:42:26.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":2397640,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 9,590,558 shares underlying options which were granted on October 13, 2023 that remain subject to the satisfaction of performance conditions."}],"balance_after":2397640,"derivative":{"exercise_price":1.68,"expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":2397640},"source":{"system":"sec-edgar","filing":"0001599298-24-000123","document":"wk-form4_1724445740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000123/wk-form4_1724445740.xml","form_type":"4"}},{"id":1424046,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-08-23T20:42:26.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 400,000 shares underlying options which were granted on September 9, 2022 that remain subject to the satisfaction of performance conditions."}],"balance_after":100000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-09-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001599298-24-000123","document":"wk-form4_1724445740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000123/wk-form4_1724445740.xml","form_type":"4"}},{"id":1424045,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-08-23T20:42:26.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":260000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 1,040,000 shares underlying options which were granted on June 28, 2022, that remain subject to the satisfaction of performance conditions."}],"balance_after":260000,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001599298-24-000123","document":"wk-form4_1724445740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000123/wk-form4_1724445740.xml","form_type":"4"}},{"id":1468079,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":26930,"kind":"person","name":"Huber Jeff","position":1,"cik":"0001463740","reported_name":"Huber Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T21:20:22.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":17883,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on June 27, 2024 and represents a pro rata amount of the annual 35,000 option board grant based approximately on the number of days the reporting person is anticipated to serve as a director in 2024. The shares underlying the option are scheduled to vest in full on December 31, 2024, subject to the director remaining as a non-salaried director on such vesting date."}],"balance_after":217883,"derivative":{"exercise_price":7.87,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":17883},"source":{"system":"sec-edgar","filing":"0001599298-24-000107","document":"wk-form4_1719523215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463740/000159929824000107/wk-form4_1719523215.xml","form_type":"4"}},{"id":1468078,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":26930,"kind":"person","name":"Huber Jeff","position":1,"cik":"0001463740","reported_name":"Huber Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T21:20:22.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 27, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on June 27, 2025, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":7.87,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001599298-24-000107","document":"wk-form4_1719523215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463740/000159929824000107/wk-form4_1719523215.xml","form_type":"4"}},{"id":1541850,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69981,"kind":"person","name":"Ronaghi Mostafa","position":1,"cik":"0001441876","reported_name":"Ronaghi Mostafa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-15T09:21:46.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":25315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on April 11, 2024 and represents a pro rata amount of the annual 35,000 option board grant based approximately on the number of days the reporting person is anticipated to serve as a director in 2024. The shares underlying the option are scheduled to vest in full on December 31, 2024, subject to the director remaining as a non-salaried director on such vesting date."}],"balance_after":225315,"derivative":{"exercise_price":4.03,"expiration_date":"2034-04-11","underlying":"Common Stock","underlying_shares":25315},"source":{"system":"sec-edgar","filing":"0001599298-24-000070","document":"wk-form4_1713187295.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441876/000159929824000070/wk-form4_1713187295.xml","form_type":"4"}},{"id":1541849,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69981,"kind":"person","name":"Ronaghi Mostafa","position":1,"cik":"0001441876","reported_name":"Ronaghi Mostafa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-15T09:21:46.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 11, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 11, 2025, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":4.03,"expiration_date":"2034-04-11","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001599298-24-000070","document":"wk-form4_1713187295.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441876/000159929824000070/wk-form4_1713187295.xml","form_type":"4"}},{"id":1547578,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38041,"kind":"person","name":"Soni Manmeet Singh","position":1,"cik":"0001569769","reported_name":"Soni Manmeet Singh","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-04T21:52:23.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":1100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 2, 2024. The shares underlying the option shall vest in four equal annual installments."}],"balance_after":1100000,"derivative":{"exercise_price":3.85,"expiration_date":"2034-04-02","underlying":"Common Stock","underlying_shares":1100000},"source":{"system":"sec-edgar","filing":"0001599298-24-000060","document":"wk-form4_1712267527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1569769/000159929824000060/wk-form4_1712267527.xml","form_type":"4"}},{"id":1547953,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69529,"kind":"person","name":"Anand Bhaskar","position":1,"cik":"0001890784","reported_name":"Anand Bhaskar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-04T17:47:15.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":600000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 2, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 2, 2025.  Note this does not include an additional 600,000 options which were granted on April 2, 2024 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets."}],"balance_after":600000,"derivative":{"exercise_price":3.85,"expiration_date":"2034-04-02","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001599298-24-000058","document":"wk-form4_1712267219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1890784/000159929824000058/wk-form4_1712267219.xml","form_type":"4"}},{"id":1559278,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:28:30.000Z","date":"2024-03-27","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.71,"value":74200.0,"ownership":{"direct":false,"nature":"Immediate family member"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.68 to $3.75 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001599298-24-000047","document":"wk-form4_1711585700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000047/wk-form4_1711585700.xml","form_type":"4"}},{"id":1559277,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:28:30.000Z","date":"2024-03-26","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":3.75,"value":112500.0,"ownership":{"direct":false,"nature":"Immediate family member"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.78 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001599298-24-000047","document":"wk-form4_1711585700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000047/wk-form4_1711585700.xml","form_type":"4"}},{"id":1559276,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:28:30.000Z","date":"2024-03-27","kind":"purchase","planned":false,"acquired":true,"shares":34321,"price":3.72,"value":127674.12,"ownership":{"direct":false,"nature":"By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.69 to $3.72 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":24923800,"source":{"system":"sec-edgar","filing":"0001599298-24-000047","document":"wk-form4_1711585700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000047/wk-form4_1711585700.xml","form_type":"4"}},{"id":1559275,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38065,"kind":"person","name":"Zanganeh Mahkam","position":1,"cik":"0001507650","reported_name":"Zanganeh Mahkam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:28:30.000Z","date":"2024-03-27","kind":"purchase","planned":false,"acquired":true,"shares":26000,"price":3.72,"value":96720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.70 to $3.73 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":520814,"source":{"system":"sec-edgar","filing":"0001599298-24-000047","document":"wk-form4_1711585700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507650/000159929824000047/wk-form4_1711585700.xml","form_type":"4"}},{"id":1559220,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:27:03.000Z","date":"2024-03-26","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":3.75,"value":375000.0,"ownership":{"direct":false,"nature":"By Dhingra Family Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.74 to $3.76 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":354958,"source":{"system":"sec-edgar","filing":"0001599298-24-000046","document":"wk-form4_1711585608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000046/wk-form4_1711585608.xml","form_type":"4"}},{"id":1642618,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69938,"kind":"person","name":"Xia Yu","position":1,"cik":"0001963544","reported_name":"Xia Yu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-14T21:35:18.000Z","date":"2023-01-17","kind":"purchase","planned":false,"acquired":true,"shares":10000000,"price":2.51,"value":25100000.0,"ownership":{"direct":false,"nature":"Akeso, Inc."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"10,000,000 shares of the Issuer's Common Stock were issued on January 17, 2023 in connection with the Collaboration and License Agreement with Akeso, Inc.(\"Akeso\") pursuant to which the Issuer issued Akeso such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 28.9% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest."}],"balance_after":10000000,"source":{"system":"sec-edgar","filing":"0001999371-24-002333","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000199937124002333/ownership.xml","form_type":"5"}},{"id":1642617,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69938,"kind":"person","name":"Xia Yu","position":1,"cik":"0001963544","reported_name":"Xia Yu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-14T21:35:18.000Z","date":"2023-03-07","kind":"purchase","planned":false,"acquired":true,"shares":21523530,"price":1.05,"value":22599706.5,"ownership":{"direct":false,"nature":"Akeso, Inc."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"21,523,530 shares of the Issuer's Common Stock were acquired on March 7, 2023 through a rights offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 28.9% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest."}],"balance_after":21523530,"source":{"system":"sec-edgar","filing":"0001999371-24-002333","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000199937124002333/ownership.xml","form_type":"5"}},{"id":1686968,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:33:49.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":21363,"price":1.32,"value":28199.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $28,200."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":56363,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":21363},"source":{"system":"sec-edgar","filing":"0001599298-24-000017","document":"wk-form4_1704404000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000017/wk-form4_1704404000.xml","form_type":"4"}},{"id":1686967,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:33:49.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-24-000017","document":"wk-form4_1704404000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000017/wk-form4_1704404000.xml","form_type":"4"}},{"id":1686966,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":95459,"kind":"person","name":"Mahatme Ujwala","position":1,"cik":"0001823894","reported_name":"Mahatme Ujwala","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:22:08.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":52575,"price":1.32,"value":69399.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $69,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":87575,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":52575},"source":{"system":"sec-edgar","filing":"0001599298-24-000010","document":"wk-form4_1704403313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000010/wk-form4_1704403313.xml","form_type":"4"}},{"id":1686965,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":95459,"kind":"person","name":"Mahatme Ujwala","position":1,"cik":"0001823894","reported_name":"Mahatme Ujwala","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:22:08.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-24-000010","document":"wk-form4_1704403313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000010/wk-form4_1704403313.xml","form_type":"4"}},{"id":1686964,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69938,"kind":"person","name":"Xia Yu","position":1,"cik":"0001963544","reported_name":"Xia Yu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:19:53.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on January 2, 2025."}],"balance_after":235000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001599298-24-000008","document":"wk-form4_1704403182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000008/wk-form4_1704403182.xml","form_type":"4"}},{"id":1686963,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69938,"kind":"person","name":"Xia Yu","position":1,"cik":"0001963544","reported_name":"Xia Yu","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:19:53.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-24-000008","document":"wk-form4_1704403182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000008/wk-form4_1704403182.xml","form_type":"4"}},{"id":1688718,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":16863,"kind":"person","name":"DUGGAN ROBERT W","position":1,"cik":"0001055919","reported_name":"DUGGAN ROBERT W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:16:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":74545,"price":1.32,"value":98399.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date."}],"balance_after":74545,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":74545},"source":{"system":"sec-edgar","filing":"0001599298-24-000006","document":"wk-form4_1704402965.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055919/000159929824000006/wk-form4_1704402965.xml","form_type":"4"}},{"id":1687146,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T16:27:25.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":47651,"price":1.32,"value":62899.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $62,900."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":82651,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":47651},"source":{"system":"sec-edgar","filing":"0001599298-24-000014","document":"wk-form4_1704403621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000159929824000014/wk-form4_1704403621.xml","form_type":"4"}},{"id":1687145,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69950,"kind":"person","name":"Booth Robert F.","position":1,"cik":"0001507567","reported_name":"Booth Robert F.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T16:27:25.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-24-000014","document":"wk-form4_1704403621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1507567/000159929824000014/wk-form4_1704403621.xml","form_type":"4"}},{"id":1687018,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T16:24:33.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":70492,"price":1.32,"value":93049.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $93,050."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":105492,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":70492},"source":{"system":"sec-edgar","filing":"0001599298-24-000012","document":"wk-form4_1704403461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929824000012/wk-form4_1704403461.xml","form_type":"4"}},{"id":1687017,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":69942,"kind":"person","name":"Clark Kenneth A","position":1,"cik":"0001561736","reported_name":"Clark Kenneth A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T16:24:33.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-24-000012","document":"wk-form4_1704403461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561736/000159929824000012/wk-form4_1704403461.xml","form_type":"4"}}],"next_cursor":"2024-01-04T16:24:33.000000Z,1687017"}